Stocks and Investing
Stocks and Investing
Tue, May 14, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Cory Kasimov Initiated (BNTX) at Hold and Held Target at $100 on, May 14th, 2024
Cory Kasimov of Evercore ISI Group, Initiated "BioNTech SE" (BNTX) at Hold and Held Target at $100 on, May 14th, 2024.
Cory has made no other calls on BNTX in the last 4 months.
There are 7 other peers that have a rating on BNTX. Out of the 7 peers that are also analyzing BNTX, 3 agree with Cory's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Yaron Werber of "TD Cowen" Maintained at Hold with Increased Target to $98 on, Tuesday, May 7th, 2024
- Eliana Merle of "UBS" Maintained at Hold with Decreased Target to $101 on, Wednesday, March 27th, 2024
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $100 on, Wednesday, February 28th, 2024
These are the ratings of the 4 analyists that currently disagree with Cory
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $113 on, Wednesday, May 8th, 2024
- Etzer Darout of "BMO Capital" Maintained at Buy with Decreased Target to $122 on, Tuesday, May 7th, 2024
- Jessica Fye of "JP Morgan" Maintained at Sell with Decreased Target to $90 on, Friday, March 22nd, 2024
- Bill Maughan of "Canaccord Genuity" Reiterated at Strong Buy and Held Target at $171 on, Thursday, March 21st, 2024
Contributing Sources